Empirical Finance’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $10.9M | Sell |
90,944
-207
| -0.2% | -$23.9K | 0.51% | 41 |
|
|
2025
Q4 | $9.59M | Sell |
91,151
-5,835
| -6% | -$548K | 0.46% | 39 |
|
|
2025
Q3 | $8.14M | Buy |
96,986
+6,356
| +7% | +$524K | 0.39% | 48 |
|
|
2025
Q2 | $7.17M | Buy |
90,630
+2,552
| +3% | +$203K | 0.38% | 49 |
|
|
2025
Q1 | $7.91M | Buy |
88,078
+1,077
| +1% | +$101K | 0.48% | 37 |
|
|
2024
Q4 | $8.65M | Sell |
87,001
-1,157
| -1% | -$119K | 0.5% | 33 |
|
|
2024
Q3 | $10M | Buy |
88,158
+1,984
| +2% | +$236K | 0.58% | 28 |
|
|
2024
Q2 | $10.7M | Sell |
86,174
-5,755
| -6% | -$741K | 0.67% | 25 |
|
|
2024
Q1 | $12.1M | Buy |
91,929
+3,067
| +3% | +$378K | 0.74% | 24 |
|
|
2023
Q4 | $9.69M | Buy |
88,862
+588
| +0.7% | +$61K | 0.68% | 25 |
|
|
2023
Q3 | $9.09M | Buy |
88,274
+8,903
| +11% | +$960K | 0.67% | 29 |
|
|
2023
Q2 | $9.16M | Buy |
79,371
+8,990
| +13% | +$1.02M | 0.71% | 26 |
|
|
2023
Q1 | $7.49M | Buy |
70,381
+3,830
| +6% | +$414K | 0.7% | 26 |
|
|
2022
Q4 | $7.38M | Buy |
66,551
+5,032
| +8% | +$514K | 0.76% | 27 |
|
|
2022
Q3 | $5.3M | Buy |
61,519
+9,996
| +19% | +$892K | 0.63% | 32 |
|
|
2022
Q2 | $4.7M | Buy |
51,523
+2,747
| +6% | +$244K | 0.6% | 32 |
|
|
2022
Q1 | $4M | Buy |
48,776
+9,907
| +25% | +$781K | 0.45% | 44 |
|
|
2021
Q4 | $2.98M | Buy |
38,869
+6,847
| +21% | +$545K | 0.35% | 56 |
|
|
2021
Q3 | $2.4M | Buy |
32,022
+1,779
| +6% | +$135K | 0.36% | 49 |
|
|
2021
Q2 | $2.35M | Buy |
30,243
+3,051
| +11% | +$227K | 0.38% | 47 |
|
|
2021
Q1 | $2.12M | Hold |
27,192
| – | – | 0.37% | 65 |
|
|
2020
Q4 | $2.12M | Buy |
27,192
+4,673
| +21% | +$357K | 0.37% | 65 |
|
|
2020
Q3 | $1.78M | Buy |
22,519
+4,551
| +25% | +$356K | 0.38% | 67 |
|
|
2020
Q2 | $1.33M | Buy |
17,968
+2,415
| +16% | +$182K | 0.34% | 83 |
|
|
2020
Q1 | $1.14M | Buy |
15,553
+5,297
| +52% | +$416K | 0.36% | 74 |
|
|
2019
Q4 | $890K | Buy |
10,256
+3,699
| +56% | +$304K | 0.22% | 109 |
|
|
2019
Q3 | $527K | Buy |
6,557
+117
| +2% | +$9.38K | 0.15% | 115 |
|
|
2019
Q2 | $515K | Sell |
6,440
-130
| -2% | -$9.95K | 0.14% | 112 |
|
|
2019
Q1 | $521K | Buy |
6,570
+1,496
| +29% | +$112K | 0.13% | 116 |
|
|
2018
Q4 | $370K | Sell |
5,074
-492
| -9% | -$34.7K | 0.11% | 114 |
|
|
2018
Q3 | $377K | Buy |
5,566
+616
| +12% | +$39.2K | 0.09% | 111 |
|
|
2018
Q2 | $287K | Sell |
4,950
-1,620
| -25% | -$91.4K | 0.07% | 108 |
|
|
2018
Q1 | $521K | Buy |
+6,570
| New | +$355K | 0.13% | 116 |
|
|
2017
Q1 | – | Sell |
-1,357
| Closed | -$77K | – | 388 |
|
|
2016
Q4 | $77K | Buy |
+1,357
| New | +$79.4K | 0.05% | 99 |
|
Other funds holding MRK
VCM
VPM
Empirical Finance's MRK Position: Q1 2026 in Review
Empirical Finance reduced its Merck (MRK) stake by 0.23% in Q1 2026, selling an estimated $23.9K and leaving 90,944 shares worth $10.9M. The position accounts for 0.51% of the portfolio, ranked #41.
Empirical Finance first reported a position in MRK in Q4 2016 and has held it in 34 quarters since. The position peaked at $12.1M in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Empirical Finance held 90,944 shares of Merck worth $10.9M as of Q1 2026.
- Empirical Finance sold 207 Merck shares in Q1 2026, an estimated $23.9K.
- Merck made up 0.51% of Empirical Finance's portfolio in Q1 2026, its #41 holding.
- Empirical Finance first reported a position in Merck in Q4 2016 and has held it in 34 quarters since.
- Empirical Finance's Merck position peaked at $12.1M in Q1 2024.
- 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Empirical Finance's 13F filing for Q1 2026, filed 14 May 2026.